论文部分内容阅读
本文从药品不良反应产品缺陷的判定,损害责任的归责原则及适用的救济体系等方面,以法律经济学角度探讨药品不良反应的救济困境。药品不良反应在现有国情下难以认定为缺陷,严格责任原则不适用不良反应损害责任,政府参与下的以基金、保险为主的损害救济模式相比诉讼程序在成本收益方面更具有效率。
This article explores the remedy dilemma of adverse drug reactions from the point of view of law and economics from the aspects of the judgment of product adverse reactions, the imputation principle of damage liability and the applicable remedy system. Adverse drug reactions are difficult to identify as defects in the existing national conditions, strict liability does not apply the principle of harmful effects of adverse reactions, the government involved in the fund, insurance-based damage relief model compared to litigation procedures in the cost-benefit more efficient.